MontaniniRRavashiniC. Psychopharmacologic treatment in relation with electroencephalography. Med Exp1961; 5: 396–405.
2.
UlettGAHeuslerAFWordTJ. The effect of psychotropic drugs on the EEG of chronic psychotic patients. In: WilsonWP (ed). Applications of Electroencephalography in Psychiatry. Duke Univ Press: Durham; 1965: 241–257.
3.
DasbergH. EEG as an outcome measurement in treatment with antipsychotic psychopharmacy. In: ItilTM (ed). Psychotropic Drugs and the Human EEG. Mod Probl Pharmacopsychiat. Vol 8. Karger: New York; 1974: 301–316.
4.
BorensteinPCujoP. Effects of major tranquillizers on the resting EEG. Mod Probl Pharmacopsychiat1974; 8: 1–21.
5.
SmallJGMilsteinVSharpleyPHKlapperMSmallIF. Electroencephalographic findings in relation to diagnostic constructs in psychiatry. Biol Psychiatry1984; 19: 471–487.
6.
ItilTMShapiroDSchneiderSJFrancisIB. Computerized EEG as a predictor of drug response in treatment resistant schizophrenics. J Nerv Ment Dis1981; 169: 629–637.
NeilJFMerikangasJRDaviesRKHimmelhochJM. Validity and clinical utility of neuroleptic-facilitated electroencephalography in psychiatric patients. Clin Electroencephalogr1978; 9: 38–48.
KoshinoY. EEG in psychiatry. Am J EEG Technol1989; 29: 219–234.
11.
DavisJMBarterJMKaneJM. Antipsychotic drugs. In: KaplanHISadockBJ (eds). Textbook of Psychiatry. Williams & Wilkins: New York; 1989: 1591–1626.
12.
DalyDD. Projected rhythms. In: RemondA (ed). Handbook of Electroencephalography and Clinical Neurophysiology. Vol 14. Part C. Elsevier: Amsterdam; 1975: 14C7–14C10.
13.
SaundersMGWestmorelandBF. The EEG in evaluation of disorders affecting the brain diffusely. In: KlassDDalyD (eds). Current Practice of Clinical Electroencephalography. Raven Press: New York; 1979: 343–380.
PostRM. Anticonvulsants adjuncts to neuroleptics in the treatment of schizoaffective and schizophrenic patients. In: PostRMTrimbleMRPippengerCE (eds). Clinical Use of Anticonvulsants in Psychiatric Disorders. Demos Publications: New York; 1989: 153–164.
18.
OkumaTYamashitaITakahashiR. A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders. Acta Psychiat Scan1989; 80: 250–259.
19.
HerreraJMSramekJJCostaJF. Efficacy of adjunctive carbamazepine in the treatment of chronic schizophrenia. Drug Intell Clin Pharmacy1987; 21: 355–358.
20.
WetterlingT. Open clinical trial of carbamazepine in chronic schizophrenic inpatients. Pharmacopsychiat1987; 20: 127–130.
21.
YoshinoMOhtaKMatsuuraM. Effect of carbamazepine on cognitive function in schizophrenics — Assessment of adjunctive use of carbamazepine for chronic schizophrenia. Ann Rep Pharmacopsychiat Res Found1993; 24: 73–80 (in Japanese with English abstract).
22.
OkumaT. A study of the use of carbamazepine against mental disorders with special reference to manic-depressive disorders and schizophrenia. Senshin-igaku1983; 25: 1305–1315 (in Japanese).
23.
BesserRHornungKTheisohnM. EEG changes in patients during the introduction of carbamazepine. Electroencephalogr Clin Neurophysiol1992; 83: 19–23.
24.
GoetzKLvan KammenDP. Computerized axial tomography scans and subtypes of schizophrenia: A review of the literature. J Nerv Ment Dis1986; 174: 31–41.
25.
SheltonRCWeinbergerDR. X-ray computerized tomography studies in schizophrenia: A review and synthesis. In: NasrallahHAWeinbergerDR (eds). Handbook of Schizophrenia. Vol 1. The Neurology of Schizophrenia. Elsevier: Amsterdam; 1986: 207–250.
26.
WeinbergerDRWagnerRLStevensJR. Neurological abnormalities in schizophrenia. Presented at Society of Biological Psychiatry. 37th Annual Meeting. Toronto, May, 1982.